English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 857757      線上人數 : 797
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋
    主頁 ‧ 登入 ‧ 上傳 ‧ 說明 ‧ 關於NHRI ‧ 管理 到手機版

    子社群

    于重元 [19/19]
    劉柯俊 [85/98]
    劉滄梧 [119/125]
    劉界元(2003-2010) [3/3]
    夏和雄(1996-2012) [26/31]
    夏興國 [51/54]
    姜乃榕 [82/94]
    常慧如 [39/44]
    張俊彥 [234/254]
    張光裕 [69/79]
    張憶壽 [103/106]
    張文祥 [52/53]
    張書銘 [89/91]
    彭汪嘉康(1996-2007) [120/126]
    施能耀 [37/43]
    李家惠 [29/29]
    李岳倫 [48/49]
    林素芳 [32/32]
    楊奕馨 [41/42]
    江士昇 [88/90]
    沈哲宏 [14/16]
    洪文俊 [88/88]
    莊雙恩 [82/91]
    蔡坤志 [32/34]
    蔡慧珍 [66/71]
    蘇勇曄 [40/40]
    蘇振良 [24/25]
    郭靜娟 [71/76]
    陳尚鴻 [45/48]
    陳振陽 [72/72]
    陳立宗 [443/510]
    陳美霞(2002-2009) [1/1]
    陳詩政 [2/2]
    陳雅雯 [38/39]
    黃智興 [55/55]
    黃道揚 [26/26]
    丁兆治(2000-2004) [5/5]
    其他 [464/471]
    劉敏(1996-2007) [60/62]
    劉玫英(2004-2006) [2/2]
    吳成文(1996-2008) [53/55]
    曾思文(1997-2007) [4/4]
    李冠德(1997-2004) [4/6]
    林景太(1999-2007) [5/5]
    楊文光(1996-1999) [21/21]
    王全正(1996-2003) [4/4]
    莊聲宏(1997-2004) [11/11]
    詹宗晃(2000-2008) [2/2]
    賴基銘(2004-2008) [41/47]
    阮麗蓉(2000-2006) [6/7]
    陳俊叡(2003-2007) [6/6]
    馬彥英(1997-1999) [1/1]
    黃奇英(2005-2007) [9/10]

    鄰近社群


    分子與基因醫學研究所 [921/964]
    生技與藥物研究所 [830/1008]
    生醫工程與奈米醫學研究所 [1214/1334]
    免疫醫學研究中心 [224/236]
    神經及精神醫學研究中心 [782/804]
    細胞及系統醫學研究所 [755/815]
    感染症與疫苗研究所 [1541/1618]
    群體健康科學研究所 [2870/3000]
    國家環境醫學研究所 [1560/1591]
    國家蚊媒傳染病防治研究中心 [102/104]
    高齡醫學暨健康福祉研究中心 [216/224]
    論壇 [2/2]
    生醫資源中心 [7/7]
    研究生培育合作學程 [188/191]
    核心儀器設施中心 [9/9]
    病理核心實驗室 [14/14]
    實驗動物中心 [8/8]
    行政管理部門 [18/18]

    社群統計


    近3年內發表的文件:335(13.91%)
    含全文筆數:2250(93.40%)

    文件下載次數統計
    下載大於0次:2250(100.00%)
    下載大於100次:2250(100.00%)
    檔案下載總次數:1611277(30.06%)

    最後更新時間: 2024-11-28 18:37

    上傳排行

    資料載入中.....

    下載排行

    資料載入中.....

    RSS Feed RSS Feed
    跳至:
    或輸入年份:
    由新到舊排序 由最舊的開始

    顯示項目176-200 / 2409. (共97頁)
    << < 3 4 5 6 7 8 9 10 11 12 > >>
    每頁顯示[10|25|50]項目

    日期題名關聯
    2023-03 ASPM activates Hedgehog and Wnt signaling to promote small cell lung cancer stemness and progression Cancer Research. 2023 Mar 15;83(6):830-844.
    2023-02-28 Adjuvant chemotherapy compared with observation in patients with T2aN0 stage IB lung adenocarcinoma Frontiers in Oncology. 2023 Feb 28;13:Article number 1096683.
    2023-02-25 Low expression of ZSCAN4 predicts unfavorable outcome in urothelial carcinoma of upper urinary tract and urinary bladder World Journal of Surgical Oncology. 2023 Feb 25;21(1):Article number 62.
    2023-02-24 Deciphering the functions of telomerase reverse transcriptase in head and neck cancer Biomedicines. 2023 Feb 24;11(3):Article number 691.
    2023-02-05 Real-world data validation of NAPOLI-1 nomogram for the prediction of overall survival in metastatic pancreatic cancer Cancers. 2023 Feb 5;15(4):Article number 1008.
    2023-02-03 MiR-455-5p suppresses PDZK1IP1 to promote the motility of oral squamous cell carcinoma and accelerate clinical cancer invasion by regulating partial epithelial-to-mesenchymal transition Journal of Experimental and Clinical Cancer Research. 2023 Feb 3;42:Article number 40.
    2023-02-01 Protein arginine methyltransferase 3: A crucial regulator in metabolic reprogramming and gene expression in cancers Cancer Letters. 2023 Feb 1;554:Article number 216008.
    2023-02 A Fc-VEGF chimeric fusion enhances PD-L1 immunotherapy via inducing immune reprogramming and infiltration in the immunosuppressive tumor microenvironment Cancer Immunology Immunotherapy. 2023 Feb;72(2):351-369.
    2023-02 ASO visual abstract: Distinct failure patterns in hypopharyngeal cancer patients receiving surgery-based versus radiation-based treatment Annals of Surgical Oncology. 2023 Feb;30(2):1182-1183.
    2023-02 Distinct failure patterns in hypopharyngeal cancer patients receiving surgery-based versus radiation-based treatment Annals of Surgical Oncology. 2023 Feb;30(2):1169-1181.
    2023-02 The association between UGT1A1 polymorphisms and treatment toxicities of liposomal irinotecan ESMO Open. 2023 Feb;8(1):Article number 100746.
    2023-02 Augmenting DSM-5 diagnostic criteria with self-attention-based BiLSTM models for psychiatric diagnosis Artificial Intelligence in Medicine. 2023 Feb;136:Article number 102488.
    2023-02 Deep-learning based breast cancer detection for cross-staining histopathology images Heliyon. 2023 Feb;9(2):Article number e13171.
    2023-01-30 Real-world effectiveness of sorafenib versus lenvatinib combined with PD-1 inhibitors in unresectable hepatocellular carcinoma Cancers. 2023 Jan 30;15(3):Article number 854.
    2023-01-27 The biological impacts of CEBPD on urothelial carcinoma development and progression Frontiers in Oncology. 2023 Jan 27;13:Article number 1123776.
    2023-01-21 Adjuvant therapy in biliary tract cancers: Oral fluoropyrimidine as a beginning Lancet. 2023 Jan 21-27;401(10372):170-171.
    2023-01-20 ARID1A loss in pancreas leads to islet developmental defect and metabolic disturbance iScience. 2023 Jan 20;26(1):Article number 105881.
    2023-01-19 Futibatinib for FGFR2-rearranged intrahepatic cholangiocarcinoma New England Journal of Medicine. 2023 Jan 19;388(3):228-239.
    2023-01-19 Actin-like protein 6A expression correlates with cancer stem cell-like features and poor prognosis in ovarian cancer International Journal of Molecular Sciences. 2023 Jan 19;24(3):Article number 2016.
    2023-01-06 Visible CCD camera-guided photoacoustic imaging system for precise navigation during functional rat brain imaging Biosensors. 2023 Jan 6;13(1):Article number 107.
    2023-01 TRPM1 promotes tumor progression in acral melanoma by activating the Ca2+/CaMKIIdelta/AKT pathway Journal of Advanced Research. 2023 Jan;43:45-57.
    2023-01 Mitochondrial phosphoenolpyruvate carboxykinase promotes tumor growth in estrogen receptor-positive breast cancer via regulation of the mTOR pathway Cancer Medicine. 2023 Jan;12(2):1588-1601.
    2023-01 A G-quadruplex stabilizer, CX-5461 combined with two immune checkpoint inhibitors enhances in vivo therapeutic efficacy by increasing PD-L1 expression in colorectal cancer Neoplasia. 2023 Jan;35:Article number 100856.
    2022-12-31 Secular trends of clinical characteristics and survival of hepatocellular carcinoma in Taiwan from 2011 to 2019 Viruses. 2022 Dec 31;15(1):Article number 126.
    2022-12-28 Imatinib use for gastrointestinal stromal tumors among older patients in Japan and Taiwan Scientific Reports. 2022 Dec 28;12:Article number 22492.

    顯示項目176-200 / 2409. (共97頁)
    << < 3 4 5 6 7 8 9 10 11 12 > >>
    每頁顯示[10|25|50]項目

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋